Saturday 28 September 2019

Miami researchers discover process to sustainably produce psilocybin using genetically engineered E Coli bacteria. Psilocybin is now in clinical trials, and medical professionals see promising results for its use in treating addiction, depression and post-traumatic stress disorder in humans.

Miami researchers discover process to sustainably produce psilocybin using genetically engineered E Coli bacteria. Psilocybin is now in clinical trials, and medical professionals see promising results for its use in treating addiction, depression and post-traumatic stress disorder in humans. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/2o0E39F
via IFTTT

No comments:

Post a Comment